Inhibition of vimentin expression has been shown to change prostate cancer cell morphology leading to reduced tumor growth in vivo[32], and thus increased expression of vimentin is expected to have aggressive tumor cell behavior as supported by our results presented in this manuscript. The gene discussed is VIM; the disease is prostate cancer.